Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.

Bulanova D, Ianevski A, Bugai A, Akimov Y, Kuivanen S, Paavilainen H, Kakkola L, Nandania J, Turunen L, Ohman T, Ala-Hongisto H, Pesonen HM, Kuisma MS, Honkimaa A, Walton EL, Oksenych V, Lorey MB, Guschin D, Shim J, Kim J, Than TT, Chang SY, Hukkanen V, Kulesskiy E, Marjomaki VS, Julkunen I, Nyman TA, Matikainen S, Saarela JS, Sane F, Hober D, Gabriel G, De Brabander JK, Martikainen M, Windisch MP, Min JY, Bruzzone R, Aittokallio T, Vähä-Koskela M, Vapalahti O, Pulk A, Velagapudi V, Kainov DE.

Viruses. 2017 Sep 25;9(10). pii: E271. doi: 10.3390/v9100271.

2.

Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.

Park DS, Jo E, Choi J, Lee M, Kim S, Kim HY, Nam J, Ahn S, Hwang JY, Windisch MP.

Eur J Med Chem. 2017 Nov 10;140:65-73. doi: 10.1016/j.ejmech.2017.09.010. Epub 2017 Sep 6.

PMID:
28923387
3.

Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry.

Min S, Lim YS, Shin D, Park C, Park JB, Kim S, Windisch MP, Hwang SB.

Front Microbiol. 2017 Jun 19;8:1129. doi: 10.3389/fmicb.2017.01129. eCollection 2017.

4.

Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.

Siddharta A, Pfaender S, Vielle NJ, Dijkman R, Friesland M, Becker B, Yang J, Engelmann M, Todt D, Windisch MP, Brill FH, Steinmann J, Steinmann J, Becker S, Alves MP, Pietschmann T, Eickmann M, Thiel V, Steinmann E.

J Infect Dis. 2017 Mar 15;215(6):902-906. doi: 10.1093/infdis/jix046.

5.

GRIM-19 Restricts HCV Replication by Attenuating Intracellular Lipid Accumulation.

Kim JH, Sung PS, Lee EB, Hur W, Park DJ, Shin EC, Windisch MP, Yoon SK.

Front Microbiol. 2017 Apr 11;8:576. doi: 10.3389/fmicb.2017.00576. eCollection 2017.

6.

A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.

Lee M, Yang J, Jo E, Lee JY, Kim HY, Bartenschlager R, Shin EC, Bae YS, Windisch MP.

Sci Rep. 2017 Mar 23;7:44676. doi: 10.1038/srep44676.

7.

Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.

Laczó J, Markova H, Lobellova V, Gazova I, Parizkova M, Cerman J, Nekovarova T, Vales K, Klovrzova S, Harrison J, Windisch M, Vlcek K, Svoboda J, Hort J, Stuchlik A.

Psychopharmacology (Berl). 2017 Feb;234(4):535-547. doi: 10.1007/s00213-016-4488-2. Epub 2016 Nov 24.

PMID:
27885411
8.

TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus.

Senís E, Mockenhaupt S, Rupp D, Bauer T, Paramasivam N, Knapp B, Gronych J, Grosse S, Windisch MP, Schmidt F, Theis FJ, Eils R, Lichter P, Schlesner M, Bartenschlager R, Grimm D.

Nucleic Acids Res. 2017 Jan 9;45(1):e3. doi: 10.1093/nar/gkw805. Epub 2016 Sep 9.

9.

In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.

ElHefnawi M, Kim T, Kamar MA, Min S, Hassan NM, El-Ahwany E, Kim H, Zada S, Amer M, Windisch MP.

PLoS One. 2016 Jul 21;11(7):e0159211. doi: 10.1371/journal.pone.0159211. eCollection 2016.

10.

Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.

Lee M, Yang J, Park S, Jo E, Kim HY, Bae YS, Windisch MP.

Antiviral Res. 2016 Aug;132:287-95. doi: 10.1016/j.antiviral.2016.07.002. Epub 2016 Jul 4.

PMID:
27387825
11.

Adamantane - A Lead Structure for Drugs in Clinical Practice.

Spilovska K, Zemek F, Korabecny J, Nepovimova E, Soukup O, Windisch M, Kuca K.

Curr Med Chem. 2016;23(29):3245-3266. Review.

PMID:
27222266
12.

Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice.

Löffler T, Schweinzer C, Flunkert S, Sántha M, Windisch M, Steyrer E, Hutter-Paier B.

Mol Cell Neurosci. 2016 Jul;74:34-41. doi: 10.1016/j.mcn.2016.03.004. Epub 2016 Mar 21.

PMID:
27013422
13.

Preface.

Fisher A, Nitsch RM, Windisch M.

Neurodegener Dis. 2016;16(1-2):5. No abstract available.

PMID:
27002178
14.

Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6).

Grünvogel O, Esser-Nobis K, Windisch MP, Frese M, Trippler M, Bartenschlager R, Lohmann V, Binder M.

Genom Data. 2015 Dec 28;7:166-70. doi: 10.1016/j.gdata.2015.12.017. eCollection 2016 Mar.

15.

Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.

Kim HY, Kong S, Oh S, Yang J, Jo E, Ko Y, Kim SH, Hwang JY, Song R, Windisch MP.

Antiviral Res. 2016 May;129:39-46. doi: 10.1016/j.antiviral.2016.01.010. Epub 2016 Feb 2.

PMID:
26850830
16.

Late-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging.

Khairnar A, Ruda-Kucerova J, Drazanova E, Szabó N, Latta P, Arab A, Hutter-Paier B, Havas D, Windisch M, Sulcova A, Starcuk Z Jr, Király A, Rektorova I.

J Neurochem. 2015 Dec 19. doi: 10.1111/jnc.13500. [Epub ahead of print]

17.

Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.

Yang S, K R J, Lim S, Choi TG, Kim JH, Akter S, Jang M, Ahn HJ, Kim HY, Windisch MP, Khadka DB, Zhao C, Jin Y, Kang I, Ha J, Oh BC, Kim M, Kim SS, Cho WJ.

J Med Chem. 2015 Dec 24;58(24):9546-61. doi: 10.1021/acs.jmedchem.5b01064. Epub 2015 Dec 8.

PMID:
26613291
18.

Development of a novel hepatitis B virus encapsidation detection assay by viral nucleocapsid-captured quantitative RT-PCR.

Ryu DK, Ahn Y, Ryu WS, Windisch MP.

Biotechniques. 2015 Nov 1;59(5):287-93. doi: 10.2144/000114354. eCollection 2015 Nov.

19.

Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase.

Lee S, Yoon KD, Lee M, Cho Y, Choi G, Jang H, Kim B, Jung DH, Oh JG, Kim GW, Oh JW, Jeong YJ, Kwon HJ, Bae SK, Min DH, Windisch MP, Heo TH, Lee C.

Br J Pharmacol. 2016 Jan;173(1):191-211. doi: 10.1111/bph.13358. Epub 2015 Nov 25.

20.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

Supplemental Content

Loading ...
Support Center